Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 44.74 |
| Open | 44.75 |
| Bid | 44.45 x 2200 |
| Ask | 44.60 x 3100 |
| Day's range | 44.30 - 44.97 |
| 52-week range | 43.33 - 68.46 |
| Volume | |
| Avg. volume | 15,315,623 |
| Market cap | 91.098B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.40 (5.34%) |
| Ex-dividend date | 04 Apr 2024 |
| 1y target est | N/A |
- Business Wire
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
PRINCETON, N.J., May 10, 2024--Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
- Business Wire
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
- Business Wire
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
© 2024 Yahoo. All rights reserved.